Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON26567
NL-OMON26567Not yet recruitingNot Applicable

Early or Late Intervention in high risk non ST elevation Acute Coronary Syndromes.

Diagram B.V.v. Nahuysplein 68011 NB ZwolleThe Netherlands0 sites540 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
540
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  1. van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ. A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J 2003;24:1401-5. 2. Savonitto S, Cohen MG, Politi A, Hudson MP, Kong DF, Huang Y, et al. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. Eur Heart J 2005;26:2106-2113. 3. de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005 26:865-72. 4. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003;290:1593-1599. 5. Mehta SR, Cannon CP, Fox KA et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-17. 6. Ripa RS, Holmvang L, Maynard C. Sejersten M, Clemmensen P, Grande P, et al. Consideration of the total ST segment deviation on the initial ECG for predicting final acute posterior myocardial infarct size in patients with maximum ST segment deviationas depression in leads V1 through V3. A FRISC-II substudy. J Electrocardiol 2005;38:180-186. 7. Buiatti E, Barchielli A, Marchionni N, Balzi D, Carrabba N, Valente S, et al. Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: Results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003;24:1195-1203.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Ischemic Chest Pain or Dyspnoe at rest with last attack < 24 hours with at least 2 out of 3 of the following characteristics:
  • •1. Evidence of extensive myocardial Ischemia on ECG:
  • •i. (New) Cumulative ST depression > 5 mm or
  • •ii. Temporary ST segment elevation in 2 contiguous leads < 30 minutes;
  • •2. Evidence of myocardial damage:
  • •i. Positive Troponin (>0.05 ng/ml) or Myoglobin (>150 microg/l) on admission or 3 hours later or
  • •ii. Positive CKmb fraction on admission (>6% of total CK);
  • •3. Age above 65 years.

Exclusion Criteria

  • •1. Persistent ST segment elevation;
  • •2. Absolute contra-indication for diagnostic angiography.;
  • •3. Active bleeding;
  • •4. Cardiogenic shock;
  • •5. Acute posterior infarction;
  • •6. Live expectancy less than 1 year.

Investigators

Sponsor
Diagram B.V.v. Nahuysplein 68011 NB ZwolleThe Netherlands

Similar Trials

Completed
Not Applicable
Early or late intervention in high risk non-ST elevation acute coronary syndromeson ST-Elevation Acute Coronary Syndrome (NSTE-ACS)Circulatory SystemCoronary diseases
ISRCTN39230163Isala Clinics (Isala klinieken) (Netherlands)540
Recruiting
Phase 1
CAR-T-cell treatment for untreated high risk MANtle Cell LymphomaMantle Cell Lymphoma (MCL)MedDRA version: 21.0Level: PTClassification code: 10026805Term: Mantle cell lymphoma stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026803Term: Mantle cell lymphoma stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026804Term: Mantle cell lymphoma stage III Class: 100000004864
CTIS2022-502405-15-01Klinikum Der Universitat Munchen AöR91
Active, not recruiting
Phase 1
Early oral antibiotics in Staphylocopccus aureus bloodstream infectio
EUCTR2013-000577-77-DEniversity of Düsseldorf430
Active, not recruiting
Not Applicable
Early oral antibiotics in Staphylocopccus aureus bloodstream infectioow risk Staphylococcus aureus bloodstream infectionMedDRA version: 18.0Level: LLTClassification code 10041943Term: Staphylococcus aureus septicaemiaSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10054638Term: Staphylococcus aureus septicemiaSystem Organ Class: 100000004862
EUCTR2013-000577-77-NLniversity of Cologne430
Active, not recruiting
Phase 1
Early oral antibiotics in Staphylocopccus aureus bloodstream infectioow risk Staphylococcus aureus bloodstream infectionMedDRA version: 17.0Level: LLTClassification code 10041943Term: Staphylococcus aureus septicaemiaSystem Organ Class: 100000004862MedDRA version: 17.0Level: LLTClassification code 10054638Term: Staphylococcus aureus septicemiaSystem Organ Class: 100000004862
EUCTR2013-000577-77-ESniversity of Cologne213
Early or Late Intervention in high risk... | Clinical Trial